The bone graft uses proprietary nanocrystalline hydroxyapatite and collagen-based biopolymer to promote bone growth in the posterolateral spine. The implantation occurred in Europe and opened the doors for global distribution.
More Articles on Spine Devices:
AxioMed Spine Receives CE Mark for cervical Disc
TransCorp Spine Names Christopher Welch President & CEO
6 New Spine Device Company Financial Reports
Pioneer Surgical Technology’s nanOss Bioactive Bone Graft Implanted in Posterolateral Spine
Pioneer Surgical Technology announced its nanOss Bioactive bone graft has been successfully implanted into a human.
Inside the referral gaps costing health systems patients and growth
Recommended Live Webinar on Mar 31, 2026 1:00 PM - 2:00 PM CST